InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

AVV Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): GBX 0

AVEVA Group Insider Trading History Chart

This chart shows the insider buying and selling history at AVEVA Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AVEVA Group Share Price & Price History

Current Price: GBX 3,219
Price Change: ▲ Price Increase of +3186.81 (9,900.00%)
As of 01/19/2023 12:59 AM ET

This chart shows the closing price history over time for AVV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

AVEVA Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/24/2022James KiddInsiderSell3GBX 2,488GBX 7,464
8/18/2021James KiddInsiderBuy25GBX 3,519£879.75
7/6/2021James KiddInsiderSell3,155GBX 3,886£122,603.30
6/1/2021Peter HerweckInsiderBuy13,500GBX 3,548£478,980
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for AVEVA Group (LON:AVV)

AVEVA Group logo
AVEVA Group plc, through its subsidiaries, provides engineering and industrial software solutions in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company offers engineering, procurement, and construction; asset performance management; monitoring and control; planning and scheduling; and operation and optimization industrial software solutions. It also provides digital transformation solutions covering artificial intelligence, cloud, digital twin, edge, extended reality, and Industrial Internet of Things products; and customer support and training services. The company serves customers in the chemicals, food and beverage, consumer packaged goods, infrastructure, life sciences, marine, mining, oil and gas, power and utilities, pulp and paper, steel fabrication, and water and wastewater industries. The company was founded in 1967 and is based in Cambridge, the United Kingdom. AVEVA Group plc is a subsidiary of Schneider Electric SE.
Read More on AVEVA Group

Today's Range

Now: GBX 3,219
Low: 3,219
High: 3,219

50 Day Range

MA: GBX 3,219
Low: 3,219
High: 3,219

52 Week Range

Now: GBX 3,219
Low: 1,800
High: 3,305

Volume

N/A

Average Volume

2,994,796 shs

Market Capitalization

£9.72 billion

P/E Ratio

N/A

Dividend Yield

1.16%

Beta

N/A

Who are the company insiders with the largest holdings of AVEVA Group?

AVEVA Group's top insider investors include:
  1. James Kidd (Insider)
Learn More about top insider investors at AVEVA Group.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...